Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A PROSPECTIVE, OPEN-LABEL, MULTICENTER RANDOMIZED PHASE III TRIAL TO COMPARE THE EFFICACY AND SAFETY OF A COMBINED REGIMEN OF OBINUTUZUMAB AND VENETOCLAX VERSUS FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR)/ BENDAMUSTINE AND RITUXIMAB (BR) IN FIT PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITHOUT DEL (17P) OR TP53 MUTATION (CO41685)

  • Details

ClinicalTrials.gov ID: NCT04285567
Diagnosis Type: Leukemia
USOR Number: 19182

  • Practice Details

1800 Williams St, Suite 200
Denver, CO 80218
P: (303) 388-4876

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A PROSPECTIVE, OPEN-LABEL, MULTICENTER RANDOMIZED PHASE III TRIAL TO COMPARE THE EFFICACY AND SAFETY OF A COMBINED REGIMEN OF OBINUTUZUMAB AND VENETOCLAX VERSUS FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR)/ BENDAMUSTINE AND RITUXIMAB (BR) IN FIT PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITHOUT DEL (17P) OR TP53 MUTATION (CO41685)

  • Details

ClinicalTrials.gov ID: NCT04285567
Diagnosis Type: Leukemia
USOR Number: 19182

  • Practice Details

4715 Arapahoe Avenue
Boulder, CO 80303
P: (303) 385-2000

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A PROSPECTIVE, OPEN-LABEL, MULTICENTER RANDOMIZED PHASE III TRIAL TO COMPARE THE EFFICACY AND SAFETY OF A COMBINED REGIMEN OF OBINUTUZUMAB AND VENETOCLAX VERSUS FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR)/ BENDAMUSTINE AND RITUXIMAB (BR) IN FIT PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITHOUT DEL (17P) OR TP53 MUTATION (CO41685)

  • Details

ClinicalTrials.gov ID: NCT04285567
Diagnosis Type: Leukemia
USOR Number: 19182

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, CO 80907
P: (719) 577-2555

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

A PROSPECTIVE, OPEN-LABEL, MULTICENTER RANDOMIZED PHASE III TRIAL TO COMPARE THE EFFICACY AND SAFETY OF A COMBINED REGIMEN OF OBINUTUZUMAB AND VENETOCLAX VERSUS FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR)/ BENDAMUSTINE AND RITUXIMAB (BR) IN FIT PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITHOUT DEL (17P) OR TP53 MUTATION (CO41685)

  • Details

ClinicalTrials.gov ID: NCT04285567
Diagnosis Type: Leukemia
USOR Number: 19182

  • Practice Details

1700 S Potomac Street
Aurora, CO 80012
P: (303) 418-7600

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: Breast Cancer
USOR Number: 17079

  • Practice Details

6031 East Woodmen Road, Suite 200
Colorado Springs, CO 80920
P: 719-577-2555

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

AN OPEN-LABEL, MULTICENTER, PHASE II TRIAL EVALUATING THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF SUBCUTANEOUS MOSUNETUZUMAB MONOTHERAPY IN PATIENTS WITH SELECT B-CELL MALIGNANCIES (ML43389)

  • Details

ClinicalTrials.gov ID: NCT05207670
Diagnosis Type: Lymphomas
USOR Number: 21356

  • Practice Details

6031 East Woodmen Road, Suite 200
Colorado Springs, CO 80920
P: 719-577-2555

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: Solid Tumors
USOR Number: 22052

  • Practice Details

8820 Huron St
Thornton, CO 80260
P: (303) 386-7622

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Pueblo

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: Solid Tumors
USOR Number: 22052

  • Practice Details

3676 Parker Blvd, Suite 350
Pueblo, CO 81008
P: (719) 296-6000

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: Solid Tumors
USOR Number: 22052

  • Practice Details

22 W Dry Creek Circle
Littleton, CO 80120
P: (303) 730-4700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Lone Tree

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: Solid Tumors
USOR Number: 22052

  • Practice Details

10107 RidgeGate Parkway, Suite 200
Lone Tree, CO 80124
P: (303) 925-0700

More Details View Practice Page